- Case report
- Open Access
Cardiopulmonary alterations by ultrasound in a patient with uncomplicated mixed malaria infection: a case report from the Amazon Basin
Malaria Journal volume 20, Article number: 330 (2021)
Information on cardiopulmonary complications in clinical malaria is sparse and diagnosis may be difficult in resource-limited areas due to lack of proper diagnostic tools and access to medical care. A case of pericardial effusion and pulmonary alterations assessed by ultrasound in a patient with uncomplicated mixed malaria infection is described.
A previously healthy 23-year-old male from the Amazon Basin was diagnosed with mixed infection of Plasmodium vivax and Plasmodium falciparum by peripheral blood smear. The patient presented with mild malaria symptoms without signs of severe malaria, but reported moderate chest pain and shortness of breath. Laboratory analyses revealed thrombocytopenia and anemia. The electrocardiogram had PR depressions and bedside ultrasound of the cardiopulmonary system showed pericardial effusion (18 mm) accompanied by multiple B-lines in the lungs, identified as vertical artifacts extending from the pleural line. Cardiac biomarkers were normal. The patient was treated according to national guidelines for malaria and suspected pericarditis, respectively. At follow-up on day 5, the pericardial effusion (9mm) and B-lines had markedly decreased. By day 21 the patient was asymptomatic, had completed the treatment, and the electrocardiogram and ultrasound findings had normalized.
This case report highlight the usefulness of bedside ultrasound to identify cardiopulmonary involvement in patients with uncomplicated malaria and relevant symptoms.
Information on cardiopulmonary complications in malaria is limited and only sporadically reported in clinical studies [1, 2]. Adequate and timely diagnosis of these complications may be difficult in low- and middle-income countries where access to healthcare facilities and diagnostic imaging tools are limited. Bedside ultrasound examination, including echocardiography and lung ultrasound (LUS), is a non-invasive tool that can detect cardiopulmonary alterations . Both modalities may be conducted outside of clinical wards and has previously been demonstrated useful in resource limited settings [2,3,4]. Pericardial effusion by echocardiography has been described in several reports of Plasmodium vivax and Plasmodium falciparum [5,6,7,8,9,10,11], but is not routinely assessed in patients with malaria. B-lines assessed by LUS are vertical artifacts starting from pleura and are caused by an increase in interstitial density. They are associated with cardiac and pulmonary conditions [1, 12] and one prior study has reported on B-lines in patients with malaria .
A case of pericardial effusion and B-lines in a patient with uncomplicated mixed malaria infection, who presented with chest pain and shortness of breath is reported. The aim of this case report is to describe the potential usefulness of ultrasound for identifying cardiopulmonary complications in relevant patients suffering from uncomplicated malaria.
A 23-year-old Brazilian male with no prior history of cardiopulmonary disease was diagnosed with P. vivax and P. falciparum by peripheral blood smear (16560 parasites/µL) in the emergency care unit (UPA, Cruzeiro do Sul, Acre, Brazil). 48 days earlier he had completed treatment for mono-infection of P. vivax (peripheral blood smear, 300 parasites/µL) with primaquine 30 mg (7 days) and chloroquine 600 mg (day 1) + 450 mg (day 2 and 3). The patient now presented with headache and chills and reported onset of stabbing chest pain and shortness of breath 3 days prior to examination.
The patient was circulatory stable (blood pressure 110/62 mmHg; heart rate 109 beats/min), auscultation of heart and lungs was normal. Axillary temperature was < 37.5 °C. Laboratory results showed inflammation (C-reactive protein 96 mg/L), thrombocytopenia (platelets 99/mm3) and moderate anemia (hemoglobin 9.2 g/dL). Liver function was slightly affected (aspartate aminotransferase 47 U/L). Cardiac biomarkers were all within normal range (pro-brain natriuretic peptide 24 pg/mL; troponins < 0.001 ng/mL). The electrocardiogram (ECG) showed PR-depressions in lead I, II, aVF and V1–V6. Ultrasound revealed pericardial effusion (18 mm) and 24 B-lines by LUS (Table 1; Fig. 1), which was assessed as the sum of B-lines in eight thoracic zones. All other echocardiographic measurements were within normal range, including left ventricular ejection fraction (> 50 %) and right ventricular function and no pleural effusions were found. Test for coronavirus by polymerase chain reaction was negative. The patient started treatment the same day with (i) primaquine 30 mg (14 days) (ii) artemether 80 mg + lumefantrine 480 mg × 2 (3 days) and (iii) colchicine 0.5 mg × 2 + ibuprofen 600 mg (7 days).
Follow-up day 5: Chest pain and shortness of breath improved after initiation of treatment and the patient reported to be compliant with the medication. The ECG showed sinus rhythm without PR-depressions. The pericardial effusion was reduced to 9 mm and 6 B-lines were observed. Blood sample analyses showed a decrease in C-reactive protein (32 mg/L) and peripheral blood smears were negative for Plasmodium species.
Follow-up day 21: The patient reported to be free from all symptoms and peripheral blood smears were negative. Ultrasound displayed no significant pericardial effusion (< 5 mm) and 0 B-lines.
This case report has two principal findings: (i) Malaria patients who present with cardiac complaints may suffer from unrecognized cardiopulmonary complications, and (ii) bedside ultrasound examination may be a useful method to identify such cardiac disturbances. Recently, a meta-analysis by Holm et al. found that cardiovascular complications in malaria are only sporadically reported and may be underestimated . Specifically, ECG and left ventricular dysfunction were among the most prevalent complications associated with malaria. As well, a clinical study from the Amazon Basin found that non-severe P. vivax infection (n = 26 outpatients) was associated with subclinical right ventricular function (i.e., lower fractional area change) in the symptomatic phase of the malaria infection . In this case, left and right ventricular function were normal at baseline and at follow-up (Table 1). By contrast, PR-depressions were seen in the ECG and pericardial effusion in the absence of myocardial affection, thus implying pericarditis [15, 16]. Colomba et al. reported similar findings in a malaria case and suggested that local inflammation might increase vascular permeability, leading to accumulation of pericardial fluid . Other suggested mechanisms include cytoadhesion of infected erythrocytes to the coronary endothelium  and release of pro-inflammatory cytokines due to vascular endothelial dysfunction in the myocardial vessels [18, 19]. Despite a plethora of proposed mechanisms, no consensus exists as to how malaria affects the heart.
Inflammatory changes also occur in the lungs during malaria [20, 21]. Although pulmonary edema represents a criteria for severe malaria infection, and is associated with high mortality, lung complications are also seen in uncomplicated cases [20, 22]. Lung impairment may appear in mono-infections of P. vivax and P. falciparum, however, occurs more frequently in mixed malaria infections . In the present case it is possible that the patient had a relapse of P. vivax followed by a superinfection of P. falciparum, increasing the risk of pulmonary involvement. Consequently, multiple B-lines by LUS were observed, indicating presence of extravascular lung water . One prior clinical study also reported B-lines in malaria patients, however, the sample size was small (n = 31), the population consisted of adults and children, and no relationship was found with degree of malaria severity, which was defined by a combination of clinical parameters and high parasite density (parasite count > 100,000/mm) .
During the follow-up examinations, the patient reported a relief in cardiac complaints which was accompanied by a concomitant decrease in pericardial effusion and B-lines. This indicates a correlation between cardiac symptoms and cardiopulmonary findings by ultrasound. Malaria patients presenting with key cardiac symptoms (i.e., chest pain, shortness of breath) could potentially constitute a high-risk group, who may benefit from ultrasound of the cardiopulmonary system as part of the early clinical assessment. Furthermore, B-lines demonstrated a dynamic nature throughout the follow-up examinations and could, on a hypothesis-generating basis, be used for monitoring of pulmonary involvement in malaria; similar to what has been reported in other patient groups such as heart failure and sepsis [2, 12, 23].
Bedside ultrasound examination represents an easily applicable diagnostic tool, which may provide accurate information for diagnosis of cardiopulmonary involvement in clinical malaria cases. LUS may be particularly useful as it can be applied by non-medical personnel with high sensitivity and specificity , and even is applicable in resource-limited settings . Timely use of ultrasound in relevant patients with malaria may possibly facilitate risk stratification, therapeutic decisions and effective management and should be explored in future prospective cohort studies of malaria patients.
This case report highlights the usefulness of bedside ultrasound to identify cardiopulmonary involvement in patients with uncomplicated malaria and relevant symptoms.
Availability of data and materials
The datasets used and analyzed during the current study are available from the corresponding author in reasonable request.
Price S, Platz E, Cullen L, Tavazzi G, Christ M, Cowie MR, et al. Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure. Nat Rev Cardiol. 2017;14:427–40.
Leopold SJ, Ghose A, Plewes KA, Mazumder S, Pisani L, Kingston HWF, et al. Point-of-care lung ultrasound for the detection of pulmonary manifestations of malaria and sepsis: an observational study. PLoS One. 2018;13:e0204832.
Bhavnani SP, Sola S, Adams D, Venkateshvaran A, Dash PK, Sengupta PP, et al. A randomized trial of pocket-echocardiography integrated mobile health device assessments in modern structural heart disease clinics. JACC Cardiovasc Imaging. 2018;11:546–57.
Gustafsson M, Alehagen U, Johansson P. Imaging congestion with a pocket ultrasound device: prognostic implications in patients with chronic heart failure. J Card Fail. 2015;21:548–54.
Ruhela M, Khandelwal G, Gupta S, Bansal A. Falciparum malaria mimicking acute myocardial infarction. J Fam Med Prim Care. 2019;8:308.
Colomba C, Trizzino M, Gioè C, Coelho F, Lopo I, Pinheiro P, et al. Malaria and the heart: Two rare case reports of Plasmodium falciparum-associated pericarditis. J Vector Borne Dis. 2017;54:372–4.
Sonambekar AA, Gupta N, Agarwal MP, Rajpal S, Aggarwal A. Plasmodium vivax-associated myopericarditis. EJCRIM. 2014;1. https://doi.org/10.12890/2014_000039.
Gupta N, Sahoo S. Plasmodium vivax induced myocarditis: a rare case report. Indian J Med Microbiol. 2013;31:180–1.
Maheshwari M, Saini T. Plasmodium vivax malaria complicated by pericardial effusion. Indian Med Gaz. 2012;145:199–201.
Franzen D, Curtius JM, Heitz W, Höpp HW, Diehl V, Hilger HH. Cardiac involvement during and after malaria. Clin Investig. 1992;70:670–3.
Ray HN, Doshi D, Rajan A, Singh AK, Singh SB, Das MK. Cardiovascular involvement in severe malaria: a prospective study in Ranchi, Jharkhand. J Vector Borne Dis. 2017;54:177–82.
Platz E, Jhund PS, Girerd N, Pivetta E, McMurray JJV, Peacock WF, et al. Expert consensus document: reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure. Eur J Heart Fail. 2019;21:844–51.
Holm AE, Gomes LC, Marinho CRF, Silvestre OM, Vestergaard LS, Biering-Sørensen T, et al. Prevalence of cardiovascular complications in malaria: a systematic review and meta-analysis. Am J Trop Med Hyg. 2021;104:1643–50.
Alencar-Filho AC, Ferreira JMBB, Salinas JL, Fabbri C, Monteiro WM, Siqueira AM, et al. Cardiovascular changes in patients with non-severe Plasmodium vivax malaria. IJC Hear Vasc. 2016;11:12–6.
Spodick DH. Electrocardiographic Sequences. Circulation. 1973;48:575–80.
Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36:2921–64.
Filho AC, de A, Guimarães, de Lacerda MV, Okoshi K, Okoshi MP. Malaria and vascular endothelium. Arq Bras Cardiol. 2014;103:165–9.
Moxon CA, Chisala NV, Wassmer SC, Taylor TE, Seydel KB, Molyneux ME, et al. Persistent endothelial activation and inflammation after Plasmodium falciparum infection in Malawian children. J Infect Dis. 2014;209:610–5.
Rose NR. Critical cytokine pathways to cardiac inflammation. J Interf Cytokine Res. 2011;31:705–10.
Val F, Machado K, Barbosa L, Salinas JL, Siqueira AM, Alecrim MGC, et al. Respiratory complications of Plasmodium vivax malaria: systematic review and meta-analysis. Am J Trop Med Hyg. 2017;97:733–43.
Taylor WRJ, Hanson J, Turner GDH, White NJ, Dondorp AM. Respiratory manifestations of malaria. Chest. 2012;142:492–505.
WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World-Health-Organization; 2015.
Kotepui M, Kotepui KU, De Jesus Milanez G, Masangkay FR. Plasmodium spp. mixed infection leading to severe malaria: a systematic review and meta-analysis. Sci Rep. 2020;10:11068.
Swamy V, Brainin P, Biering-Sørensen T, Platz E. Ability of non-physicians to perform and interpret lung ultrasound: a systematic review. Eur J Cardiovasc Nurs. 2019;18:474–83.
AW was supported by the Danish Heart Association (20-R139-A9644-22165). PB was supported by a research Grant from The Independent Research Fund Denmark (0129-00003B), A.P. Møllers Lægefond and Dansk Medicinsk Selskab København. LCG: CNPq (142306/2020-7). CRFM: FAPESP (2020/06747-4) and CNPq (302917/2019-5).
Ethics approval and consent to participate
The study was approved by a local scientific ethical committee and by the Brazilian Institutional Review Board (CAAE 26552619.6.0000.510/4.056.296). The study complied with the 2nd Declaration of Helsinki, and the patient gave written informed consent.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wegener, A., Lima, K.O., Holm, A.E. et al. Cardiopulmonary alterations by ultrasound in a patient with uncomplicated mixed malaria infection: a case report from the Amazon Basin. Malar J 20, 330 (2021). https://doi.org/10.1186/s12936-021-03861-5
- Heart disease
- Pericardial effusion
- Lung ultrasound